Secunder membranosus glomerulonephritis.

Translated title of the contribution: Secondary membranous glomerulonephritis

G. Mohácsi, A. Mágori, J. Ormos, G. Abrahám, G. Pokorny, S. Sonkodi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Following 689 percutaneous renal biopsies, membranous glomerulonephritis was proved in 68 patients. In 16 (23.5%) an underlying primary disease was verified, and thus the glomerulonephritis the secondary form. The primary disease was SLE in 5 cases, diabetes mellitus in 5 cases, rheumatoid arthritis in 3 cases, chronic active hepatitis in 2 cases, an ulcerative colitis and eosinophilic angiolymphoid hyperplasia in 1 patient. As initial sign, nephrotic syndrome emerged in 87.5% of the 16 cases. Microscopic haematuria was observed in half of the patients, as was hypertension, while acute renal failure presented in only 1 case. Histologically, in 13 cases the predominance of early glomerular alterations was characteristic, while in 9 cases the picture proved to be equivocal and accompanied by some degree of interstitial alterations. During combined treatment, remission was achieved in 75%. Two patients with SLE died, but not as a consequence of renal failure. Transient side-effects of the treatment were registered in 5 cases. The principal pathogenetic and clinical differences between the individual secondary nephritis forms, and the difficulty of their differentiation from the idiopathic cases, even on repeated examination, are emphasized. In 3 patients the possibility of secondary renal processes was suggested by the histological picture, and this was proved by the detailed clinical findings.

Original languageHungarian
Pages (from-to)115-119
Number of pages5
JournalOrvosi Hetilap
Volume132
Issue number3
Publication statusPublished - Jan 20 1991

Fingerprint

Membranous Glomerulonephritis
Kidney
Nephritis
Nephrotic Syndrome
Hematuria
Chronic Hepatitis
Glomerulonephritis
Ulcerative Colitis
Acute Kidney Injury
Individuality
Hyperplasia
Renal Insufficiency
Rheumatoid Arthritis
Diabetes Mellitus
Hypertension
Biopsy
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mohácsi, G., Mágori, A., Ormos, J., Abrahám, G., Pokorny, G., & Sonkodi, S. (1991). Secunder membranosus glomerulonephritis. Orvosi Hetilap, 132(3), 115-119.

Secunder membranosus glomerulonephritis. / Mohácsi, G.; Mágori, A.; Ormos, J.; Abrahám, G.; Pokorny, G.; Sonkodi, S.

In: Orvosi Hetilap, Vol. 132, No. 3, 20.01.1991, p. 115-119.

Research output: Contribution to journalArticle

Mohácsi, G, Mágori, A, Ormos, J, Abrahám, G, Pokorny, G & Sonkodi, S 1991, 'Secunder membranosus glomerulonephritis.', Orvosi Hetilap, vol. 132, no. 3, pp. 115-119.
Mohácsi G, Mágori A, Ormos J, Abrahám G, Pokorny G, Sonkodi S. Secunder membranosus glomerulonephritis. Orvosi Hetilap. 1991 Jan 20;132(3):115-119.
Mohácsi, G. ; Mágori, A. ; Ormos, J. ; Abrahám, G. ; Pokorny, G. ; Sonkodi, S. / Secunder membranosus glomerulonephritis. In: Orvosi Hetilap. 1991 ; Vol. 132, No. 3. pp. 115-119.
@article{e64d10c1e8ed4e6bbdebd2495ffac4c9,
title = "Secunder membranosus glomerulonephritis.",
abstract = "Following 689 percutaneous renal biopsies, membranous glomerulonephritis was proved in 68 patients. In 16 (23.5{\%}) an underlying primary disease was verified, and thus the glomerulonephritis the secondary form. The primary disease was SLE in 5 cases, diabetes mellitus in 5 cases, rheumatoid arthritis in 3 cases, chronic active hepatitis in 2 cases, an ulcerative colitis and eosinophilic angiolymphoid hyperplasia in 1 patient. As initial sign, nephrotic syndrome emerged in 87.5{\%} of the 16 cases. Microscopic haematuria was observed in half of the patients, as was hypertension, while acute renal failure presented in only 1 case. Histologically, in 13 cases the predominance of early glomerular alterations was characteristic, while in 9 cases the picture proved to be equivocal and accompanied by some degree of interstitial alterations. During combined treatment, remission was achieved in 75{\%}. Two patients with SLE died, but not as a consequence of renal failure. Transient side-effects of the treatment were registered in 5 cases. The principal pathogenetic and clinical differences between the individual secondary nephritis forms, and the difficulty of their differentiation from the idiopathic cases, even on repeated examination, are emphasized. In 3 patients the possibility of secondary renal processes was suggested by the histological picture, and this was proved by the detailed clinical findings.",
author = "G. Moh{\'a}csi and A. M{\'a}gori and J. Ormos and G. Abrah{\'a}m and G. Pokorny and S. Sonkodi",
year = "1991",
month = "1",
day = "20",
language = "Hungarian",
volume = "132",
pages = "115--119",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "3",

}

TY - JOUR

T1 - Secunder membranosus glomerulonephritis.

AU - Mohácsi, G.

AU - Mágori, A.

AU - Ormos, J.

AU - Abrahám, G.

AU - Pokorny, G.

AU - Sonkodi, S.

PY - 1991/1/20

Y1 - 1991/1/20

N2 - Following 689 percutaneous renal biopsies, membranous glomerulonephritis was proved in 68 patients. In 16 (23.5%) an underlying primary disease was verified, and thus the glomerulonephritis the secondary form. The primary disease was SLE in 5 cases, diabetes mellitus in 5 cases, rheumatoid arthritis in 3 cases, chronic active hepatitis in 2 cases, an ulcerative colitis and eosinophilic angiolymphoid hyperplasia in 1 patient. As initial sign, nephrotic syndrome emerged in 87.5% of the 16 cases. Microscopic haematuria was observed in half of the patients, as was hypertension, while acute renal failure presented in only 1 case. Histologically, in 13 cases the predominance of early glomerular alterations was characteristic, while in 9 cases the picture proved to be equivocal and accompanied by some degree of interstitial alterations. During combined treatment, remission was achieved in 75%. Two patients with SLE died, but not as a consequence of renal failure. Transient side-effects of the treatment were registered in 5 cases. The principal pathogenetic and clinical differences between the individual secondary nephritis forms, and the difficulty of their differentiation from the idiopathic cases, even on repeated examination, are emphasized. In 3 patients the possibility of secondary renal processes was suggested by the histological picture, and this was proved by the detailed clinical findings.

AB - Following 689 percutaneous renal biopsies, membranous glomerulonephritis was proved in 68 patients. In 16 (23.5%) an underlying primary disease was verified, and thus the glomerulonephritis the secondary form. The primary disease was SLE in 5 cases, diabetes mellitus in 5 cases, rheumatoid arthritis in 3 cases, chronic active hepatitis in 2 cases, an ulcerative colitis and eosinophilic angiolymphoid hyperplasia in 1 patient. As initial sign, nephrotic syndrome emerged in 87.5% of the 16 cases. Microscopic haematuria was observed in half of the patients, as was hypertension, while acute renal failure presented in only 1 case. Histologically, in 13 cases the predominance of early glomerular alterations was characteristic, while in 9 cases the picture proved to be equivocal and accompanied by some degree of interstitial alterations. During combined treatment, remission was achieved in 75%. Two patients with SLE died, but not as a consequence of renal failure. Transient side-effects of the treatment were registered in 5 cases. The principal pathogenetic and clinical differences between the individual secondary nephritis forms, and the difficulty of their differentiation from the idiopathic cases, even on repeated examination, are emphasized. In 3 patients the possibility of secondary renal processes was suggested by the histological picture, and this was proved by the detailed clinical findings.

UR - http://www.scopus.com/inward/record.url?scp=0026428074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026428074&partnerID=8YFLogxK

M3 - Article

C2 - 1996201

AN - SCOPUS:0026428074

VL - 132

SP - 115

EP - 119

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 3

ER -